Journal profile · Medicine-Pathology and Forensic Medicine
Diagnostic Histopathology
ISSN 1756-2317 · eISSN 1876-7621 · Elsevier
Diagnostic Histopathology: subscription journal; APC about USD 2,700; 100 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Diagnostic Histopathology is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Breast Lesions and Carcinomas and Lymphoma Diagnosis and Treatment, together about 23% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
This monthly review journal aims to provide the practising diagnostic pathologist and trainee pathologist with up-to-date reviews on histopathology and cytology and related technical advances.Each issue contains invited articles on a variety of topics from experts in the field and includes a mini-symposium exploring one subject in greater depth. Articles consist of system-based, disease-based reviews and illustrated case reports. They update the readers on day-to-day diagnostic work and keep them informed of important new developments. The journal aims to cover the main breadth of histopathology in a three year cycle.Both the contributors and readership are seen as being International. The trend toward continuing education/accreditation has a strong influence in the shaping of the journal's content and is reflected in the inclusion of a self-assessment section.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pathology and Forensic Medicine
Editor-in-chief Adrian BatemanPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 11, United States 5, Spain 2, Canada 2, Portugal 1 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine9.7%
- Breast Lesions and CarcinomasMedicine6.7%
- Lymphoma Diagnosis and TreatmentMedicine6.6%
- Metastasis and carcinoma case studiesMedicine4.7%
- Cancer and Skin LesionsMedicine4.5%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.5%
- Viral-associated cancers and disordersMedicine4.5%
- Neuroendocrine Tumor Research AdvancesMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pathology and Forensic Medicine | Q4 | 162/209 | 22nd |
| Histology | Q4 | 52/62 | 16th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.9LetPub ·
- CiteScore (publisher)
- 1.3Publisher website ·
- SJR 2026-06
- 0.24LetPub ·
- SNIP 2026-06
- 0.34LetPub ·
- h-index
- 32OpenAlex ·
- i10-index
- 165OpenAlex ·
- 2-year mean citedness
- 0.68OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 1,584 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 86 | 3 | 481 |
| 2025 | 100 | 6 | 596 |
| 2024 | 95 | 7 | 551 |
| 2023 | 82 | 14 | 524 |
| 2022 | 77 | 10 | 538 |
| 2021 | 82 | 13 | 581 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,700 / EUR 2,360 / GBP 2,120 / JPY 290,160 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Reference style
- Vancouver
- Highlights
- Optional
Article types accepted1
- case reportFor case reports you are required to follow CARE guidelines and provide the CARE checklist at manuscript submission.Read the CARE guidelinesFollow the CARE chec…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of one reviewer for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Rea…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed, does not count as prior publication Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 1756-2317
- Electronic ISSN
- 1876-7621
- Official links
- Journal homepage ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Diagnostic Histopathology
What are the manuscript requirements of Diagnostic Histopathology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Reference style: Vancouver; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Diagnostic Histopathology based?
Of the 22 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (11), United States (5) and Spain (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Diagnostic Histopathology?
According to LetPub and DOAJ records, Diagnostic Histopathology is indexed in Scopus.
Is Diagnostic Histopathology open access, and what is the APC?
Diagnostic Histopathology is a subscription journal. APC about USD 2,700.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .